SISCAPA Assay Technologies Snyder Lab Combines Microsampling, Multiomics for Health Tracking, Biomarker Discovery Premium The Stanford researcher and his colleagues have launched a pair of companies, Iollo and RHTM, to commercialize the approach. Waters, SISCAPA Assay Technologies Develop Mass Spec Test for SARS-CoV-2 Premium The companies said that they envisioned the test, which is currently RUO, as potentially part of a mass spectrometry-based respiratory virus panel. The Decade in Proteomics: Most Significant New Instrumentation Premium Highlights included mass spec-focused developments like data-independent acquisition and ion mobility along with platforms including Thermo Fisher's Q Exactive. Plasma Proteomics Seeing Renewed Interest as Mass Spec Technology Advances Premium While the approach lost some of its luster after failing to deliver on early hype, technological improvements are revitalizing interest among researchers. Studies Suggest Challenges Remain for Dried Blood Spot Protein Assays Premium Enthusiasm for dried blood spot samples is building among clinical proteomic researchers and companies, but recent work suggests technical hurdles remain. Jul 13, 2017 Waters Licenses Mass Spec Standardization Tech From SISCAPA Feb 10, 2017 Turnkey Clinical Mass Spec Solution on Horizon, Industry Analyst Suggests Premium Jul 21, 2016 SAT Developing Longitudinal Protein Panel Using Mass Spec, Dried Blood Spots Premium Jan 15, 2016 Emerging Proteomic Technologies: MALDI-TOF for Clinical Protein Quantitation Premium Oct 2, 2015 Sciex Moves to Develop Protein Quant Content With Fred Hutch-CPTAC Immuno-MRM Deal Premium Jul 23, 2015 SISCAPA Assay Technologies Taking Aim at Clinical Market Premium Nov 7, 2014 Precision Antibody Completes SBIR Contract to Generate Antibodies for SISCAPA Assays Premium Jun 11, 2014 New England Peptide, SISCAPA Collaborate on Peptide Standards May 27, 2014 Agilent, SAT Ink Pact to Provide Automated SISCAPA Workflows for Protein Quantitation May 16, 2014 SISCAPA Assay Technologies Closes Series A Funding Round Premium May 2, 2014 People in the News: Gustavo Salem, Michael Liang, Charles Wagner Premium Apr 11, 2014 New Products: SISCAPA, Mayo, Thermo Fisher, Waters Premium Mar 14, 2014 SISCAPA Assay Tech Exploring Dried Blood Spot Sampling for Mail-in, Longitudinal Proteomic Testing Premium Mar 14, 2014 People in the News: Selena Larkin Premium Mar 7, 2014 At MSACL 2014, Advances in MS-based Clinical Proteomics Draws Increased Scrutiny of Field's Methods Premium Sep 16, 2013 Bruker, SAT Ink Deal to Continue Collaboration on SISCAPA-MALDI Protein Assays Aug 2, 2013 New Study Further Bolsters Case for Bruker's MALDI Biotyper as Broad Clinical Proteomics Platform Premium Mar 15, 2013 Driven by Potential Cost Savings, Convenience, Proteomics Explores Dried Blood Spot Analysis Premium Jan 11, 2013 At JP Morgan Mass Spec Vendors Highlight Clinical Efforts, Performance of High-Profile Releases Premium Jan 4, 2013 LBNL Researchers Launch Firm to Commercialize Multinozzle Emitter Technology for Nanoflow-ESI-MS Premium Load More Breaking News Promega to Develop Microsatellite Instability Companion Diagnostic Kit With GlaxoSmithKline ZeptoMetrix Quality Control Products Receive IVDR Certification Verily Awarded CDC Contract for Wastewater Surveillance Genomic Health to Pay $32.5M to Resolve Cancer Test False Claims Allegations by DOJ Vela Diagnostics Inks Japan Distribution Agreement for HIV-1 Drug Resistance Tests The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.